Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticolimbic Degeneration and Treatment of Dementia
NCT00768261Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2004
- Primary completion
- Oct 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Washington University School of Medicine. Started Nov 2004; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00768261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00768261.